# Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

> **NCT00199095** · PHASE4 · COMPLETED · sponsor: **Goethe University** · enrollment: 40 (—)

## Conditions studied

- Adult Acute Lymphocytic Leukemia

## Interventions

- **DRUG:** Adriamycin
- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Dexamethasone
- **DRUG:** Idarubicin
- **DRUG:** Ifosfamide
- **DRUG:** Methotrexate
- **DRUG:** Mercaptopurine
- **DRUG:** VM26
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT00199095
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199095, "Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00199095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
